ProofPilot, the industry’s first end-to-end Clinical Experience Platform (CXP), purpose-built for recruitment and engagement for all study stakeholders, announced its partnership with the Digital Medicine Society (DiMe), the global non-profit dedicated to driving broad adoption of digital approaches to advance the practice of medicine to enhance public health. Through this collaboration, ProofPilot and DiMe, along with other industry leaders, will drive forward the data-driven development of innovative digital tools for clinical research, prioritizing diverse, accessible, and participant-centered study experiences. The collaboration will work to define and collect physiological signals, behavior traits, and mental health characteristics that will be used to train a tool to prevent opioid use disorder (OUD) relapse.
This collaboration supports DiMe’s mission to advance the safe, effective, and equitable use of digital approaches to redefine healthcare and improve lives. By utilizing ProofPilot’s CoPilot platform, DiMe will enhance study experiences, simplify data collection, and equip sites and participants with streamlined, compliant digital solutions.
Health Technology Insights: Johnson & Johnson TAR-200 Monotherapy Shows High Complete Response in Bladder Cancer
“Partnering with DiMe aligns with our mission to improve clinical trials through digital innovation,” said Chris Venezia, CEO of ProofPilot. “Together, we’re bringing digital solutions to the forefront of clinical research, creating streamlined, patient-centered experiences and empowering all participants with advanced tools and support.”
The ProofPilot Clinical Experience platform, deployed across a range of studies – including drug, device, real-world evidence, observational, and behavioral research – will provide DiMe with the technology and engagement tools needed to make clinical trials more efficient and accessible.
Reflecting on the collaboration, Candice Taguibao, Associate Program Director for DiMe, said, “We greatly appreciate the level of engagement and support from the entire ProofPilot team. Their dedication to advancing digital health aligns very well with our mission. We’re excited to work together to implement patient-centered approaches to clinical research and obtain insights to support the development of a digitally derived tool to help prevent relapse and reduce OUD deaths.”
Health Technology Insights: Medtronic URO U.S. Trial Meets Safety, Effectiveness Goals
This partnership with DiMe reflects ProofPilot’s commitment to advancing digital health solutions that meet the needs of diverse populations and deliver measurable impact for patient health. The collaboration underscores ProofPilot’s dedication to setting new standards in clinical research by facilitating innovative, patient-friendly digital solutions that address some of the most pressing health challenges.
Health Technology Insights: Symphony Robotics Appoints Dr. Neil A. Martin as CMO to Lead Glioblastoma Innovation
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
